Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹-28 Cr₹-37 Cr₹76 Cr₹19 Cr₹155 Cr

What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA is ₹-28 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹-28 Cr
Mar2025₹-37 Cr
Mar2024₹76 Cr
Mar2023₹19 Cr
Mar2022₹155 Cr

How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹-28 Cr
Negative
Mar2025 ₹-37 Cr
Negative
Mar2024 ₹76 Cr
290.95
Mar2023 ₹19 Cr
-87.48
Mar2022 ₹155 Cr -

Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,421.9 Cr 2.1% 7.1% -0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹107,770.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -0.2% 2.5% -3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.1%

7.1%

-0.6%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses